Cargando…
Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
Patients with non-small-cell lung cancer (NSCLC) have a low survival rate. Long non-coding RNA (LncRNA) LANCL1 antisense RNA 1 (LANCL1-AS1) was indicated to be downregulated in NSCLC; however, its detailed function in NSCLC is unanswered. Real-time quantitative polymerase chain reaction revealed the...
Autores principales: | Pan, Hui, Peng, Jing, Qiao, Xiaoni, Gao, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024345/ https://www.ncbi.nlm.nih.gov/pubmed/36941990 http://dx.doi.org/10.1515/med-2023-0666 |
Ejemplares similares
-
Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma
por: Sun, Qiang, et al.
Publicado: (2021) -
USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis
por: Wei, Guojun, et al.
Publicado: (2020) -
lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB
por: Peng, Shuangqin, et al.
Publicado: (2022) -
LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis
por: Zhu, Huaqiang, et al.
Publicado: (2020) -
LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis
por: Wu, Dianchao, et al.
Publicado: (2020)